PFE: Pfizer Inc. Stock

by  •  • Comments Off on PFE: Pfizer Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 250,723.22
Enterprise Value ($M) 287,866.22
Book Value ($M) 68,865.00
Book Value / Share 12.30
Price / Book 3.64
NCAV ($M) -50,791.00
NCAV / Share -9.07
Price / NCAV -4.94

Profitability (mra)
Return on Invested Capital (ROIC) 0.12
Return on Assets (ROA) 0.07
Return on Equity (ROE) 0.20

Liquidity (mrq)
Quick Ratio 1.12
Current Ratio 1.37

Balance Sheet (mrq) ($M)
Current Assets 48,814.00
Assets 169,920.00
Liabilities 99,605.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G State Street Corp 5.03 -4.37
02-10 13G/A Vanguard Group Inc 8.06 -0.44
01-29 13G/A BlackRock Inc. 7.10 -6.86

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 4, 2021 ☐ TRANSITION REPORT PURSUANT TO SE
2021-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 4, 2021 ☐ TRANSITION REPORT PURSUANT TO S
2021-02-25 10-K Annual Report – 10-K
2020-11-05 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-09-15 3,215,743 22,059,681 14.58
2021-09-14 3,090,581 21,579,839 14.32
2021-09-13 4,434,553 32,321,517 13.72

(click for more detail)

(click for list of largest short owners)

Similar Companies
NVS – Novartis AG OGN – Organon & Co.
PBH – Prestige Brands Holdings, Inc. PRGO – Perrigo Company PLC
QGEN – QIAGEN N.V.


Financial data and stock pages provided by
Fintel.io